European Journal of Integrative Medicine
Volume 2, Issue 2 , Pages 71-77 , June 2010

Immune messengers in Neuralgia Inducing Cavitational Osteonecrosis (NICO) in jaw bone and systemic interference

  • J. Lechner

      Affiliations

    • Grünwalder Str. 10A, D-81547 München, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 89 697 00 55; fax: +49 89 692 58 30.
    web address
    • ,
  • W. Mayer

      Affiliations

    • Immumed – Gesellschaft für angewandte Immunologie, Goethestraße 10, D-80336 München, Germany
    • Tel.: +49 89 543 21 77 89; fax: +49 89 543 21 77 82.

Received 7 January 2010 ,Revised 24 March 2010 ,Accepted 31 March 2010.

References 

  1. Black GV. A work on special dental pathology. 2nd ed.. Chicago: Medico-Dental Publ. Co.; 1920;
  2. Fischer MH. Death and dentistry. Springfield, IL: Charles C. Thomas Pub.; 1941;
  3. Bouquot JE, Roberts AM, Person P, Christian J. NICO (neuralgia-inducing cavitational osteonecrosis): osteomyelitis in 224 jawbone samples from patients with facial neuralgias. Oral Surg Oral Med Oral Pathol. 1992;73:307–319
  4. Bouquot JE. Neuralgia-inducing cavitational osteonecrosis (NICO). Oral Surg Oral Med Oral Pathol. 1992;73:307–319
  5. Bouquot JE, Christian J. Longterm effects of jawbone curettage on the pain of facial neuralgia. J Oral Maxillofac Surg. 1995;53:387–397
  6. Lechner J. Störfelder im Trigeminusbereich und Systemerkrankung. VGM Kötzting; 1999;
  7. Bouquot JE, Martin W, Wrobleski G. Computer-based thru-transmission sonography (CTS) imaging of ischemic osteonecrosis of the jaws—a preliminary investigation of 6 cadaverjaws and 15 pain patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92:550
  8. Bouquot JE, Shankland WE, Margolis M. Through-transmission alveolar ultrasonography (TAU)—new technology for evaluation of bone density and desiccation. Comparison with radiology of 170 biopsied alveolar sites of osteoporotic and ischemic disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:
  9. Lechner J. Herd, regulation und information. Heidelberg: Hüthig-Verlag; 1993;
  10. Lechner J. Fakt oder Fiktion—Dokumentation des NICO-Störfelds, RegulationsMedizin 8. Heft. 2003;2:
  11. Liu C, Papewalis C, Domberg J, Scherbaum WA, Schott M. Chemokines and autoimmune thyroid diseases. Horm Metab Res. 2008;40(June (6)):361–368[Epub April 16, 2008]
  12. Kraaijeveld AO, de Jager SC, de Jager WJ, Prakken BJ, McColl SR, Haspels I, et al. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation. 2007;116(October (17)):1931–1941[Epub October 1, 2007]
  13. Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat. 2007;14(October (10)):675–687
  14. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost. 2003;89(March (3)):506–512
  15. Słotwiński R, Olszewski WL, Paluszkiewicz R, Zieniewicz K, Hevelke P, Zaleska M, et al. Serum cytokine concentration after liver lobe harvesting for transplantation. Ann Transpl. 2002;7(3):36–39
  16. Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl. 1998;283(October):2–37
  17. Lind M, Deleuran B, Thestrup-Pedersen K, Søballe K, Eriksen EF, Bünger C. Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS. 1995;103(February (2)):140–146
  18. Robak E, Woźniacka A, Sysa-Jedrzejowska A, Stepień H, Robak T. Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw. 2001;12(July–September (3)):445–452
  19. Urbaska-Rys H, Wierzbowska A, Robak T. Circulating angiogenic cytokines in multiple myeloma and related disorders. Eur Cytokine Netw. 2003;14(January–March (1)):40–51
  20. Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. J Physiol Pharmacol. 2006;57(June (2)):189–197
  21. Hirano F, Kobayashi A, Hirano Y, Nomura Y, Fukawa E, Makino I. Thrombin-induced expression of RANTES mRNA through protease activated receptor-1 in human synovial fibroblasts. Ann Rheum Dis. 2002;61(9):834–837
  22. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, McColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem. 1993;268(8):5834–5839
  23. Chicheportiche Y, Chicheportiche R, Sizing I, Thompson J, Benjamin CB, Ambrose C, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res. 2002;4(2):126–133
  24. Conlon K, Lloyd A, Chattopadhyay U, Lukacs N, Kunkel S, Schall T, et al. CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1 alpha, interleukin-8 and RANTES. Europ J Immunol. 1995;25(3):751–756
  25. Kimura Y, Pawankar R, Aoki M, Niimi Y, Kawana S. Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES. Clin Exp Allergy. 2002;32(12):1787–1793
  26. Staruch MJ, Camacho R, Dumont FJ. Distinctive calcineurin-dependent (FK506-sensitive) mechanisms regulate the production of the CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES vs IL2 and TNF-alpha by activated human T cells. Cell Immunol. 1998;190(2):121–131
  27. Bolin LM, Murray R, Lukacs NW, Strieter RM, Kunkel SL, Schall TJ, et al. Primary sensory neurons migrate in response to the chemokine RANTES. J Neuroimmunol. 1998;81(1–2):49–57
  28. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Nature. 2007;449(7162):557–563
  29. Immumed, Gesellschaft für angewandte Immunologie, Goethestraße 10, 80336 München, Germany.
  30. Gemeinschaftspraxis für Pathologie & Zytologie, Drs. Zwicknagel/Aßmus, 85635 Freising, Germany.

PII: S1876-3820(10)00026-0

doi: 10.1016/j.eujim.2010.03.004

European Journal of Integrative Medicine
Volume 2, Issue 2 , Pages 71-77 , June 2010

Article Tools

* Image Usage & Resolution